Review Camptothecin: Current Perspectives

Qing-Yong      Li; Yuan-Gang      Zu; Rong-Zhen      Shi; Li-Ping      Yao

Abstract

The review provides a detailed discussion of recent advances in the medicinal chemistry of camptothecin, a potent antitumor agent that targets topoisomerase I. Thousands of CPT derivatives have been synthesized. Two of them, Topotecan and Irinotecan, are commercially approved for use in clinic as antitumor agents while more are still in clinic trials. This review summarizes the current status of the modern synthetic approaches to CPT, the mechanism of action of CPT, the structure-activity relationship(SAR), a number of novel CPT analogs and their biologic activity. There is a systematic evaluation of A-, B- and E-ring- modified camptothecins reported recently.

Keywords: Camptothecin, Antitumor, Topo I inhibitor

« Previous Next »